3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
4
Recruiting
3
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
705
Carcinoma, Non-Small-Cell Lung
473
Prostatic Neoplasms
423
Neoplasms
384
Multiple Myeloma
266
Colorectal Neoplasms
257
Lung Neoplasms
245
Neoplasm Metastasis
234
Melanoma
219
Leukemia, Myeloid, Acute
193
Ovarian Neoplasms
189
Pancreatic Neoplasms
177
Squamous Cell Carcinoma of Head and Neck
160
Carcinoma, Renal Cell
146
Recurrence
144
Lymphoma
144
Glioblastoma
142
Lymphoma, Non-Hodgkin
136
Stomach Neoplasms
128
Triple Negative Breast Neoplasms
127
Leukemia, Lymphocytic, Chronic, B-Cell
123
Brain Neoplasms
123
Carcinoma, Hepatocellular
122
Head and Neck Neoplasms
116
Uterine Cervical Neoplasms
115
Urinary Bladder Neoplasms
115
Precursor Cell Lymphoblastic Leukemia-Lymphoma
115
Lymphoma, Large B-Cell, Diffuse
104
Sarcoma
103
Lymphoma, Follicular
100
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Interventional
×
Lymphatic Abnormalities
×
Clear all
NCT06239480
2026-03-27
SELVA
Palvella Therapeutics, Inc.
Phase 3
Active not recruiting
51 enrolled